why choose us

First received: March 22, 2023

Clinical Trial: Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Study Status: Completed

Recruit Status: RECRUITING

Condition: Recurrent Acute Myeloid Leukemia

Study Type: INTERVENTIONAL


Official Title: Phase 2 Study of Decitabine and Cedazuridine in Combination With Venetoclax for AML Relapse After Allogeneic Hematopoietic Cell Transplantation

Brief Summary: This phase II trial tests how well decitabine and cedazuridine (DEC-C) works in combination with venetoclax in treating acute myeloid leukemia (AML) in patients whose AML has come back after a period of improvement (relapse) after a donor stem cell transplant.Cedazuridine is in a class of medications called cytidine deaminase inhibitors.It prevents the breakdown of decitabine, making it more available in the body so that decitabine will have a greater effect.Decitabine is in a class of medications called…

Read more